These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 26332059)
21. Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: single-center experience. Kondo T; Ikezawa E; Takagi T; Kobayashi H; Hashimoto Y; Iizuka J; Omae K; Yoshida K; Tanabe K Int J Urol; 2013 Nov; 20(11):1072-7. PubMed ID: 23421632 [TBL] [Abstract][Full Text] [Related]
22. Oncological outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: a single-institution study with >or=3 years of follow-up. Bandi G; Christian MW; Hedican SP; Moon TD; Nakada SY BJU Int; 2008 Feb; 101(4):459-62. PubMed ID: 17941924 [TBL] [Abstract][Full Text] [Related]
23. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704 [TBL] [Abstract][Full Text] [Related]
24. Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens. Kusuda Y; Miyake H; Behnsawy HM; Fukuhara T; Inoue TA; Fujisawa M Urol Oncol; 2013 Jan; 31(1):42-50. PubMed ID: 21396851 [TBL] [Abstract][Full Text] [Related]
26. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291 [TBL] [Abstract][Full Text] [Related]
27. Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma? Méjean A; Rouprêt M; Larousserie F; Hopirtean V; Thiounn N; Dufour B J Urol; 2003 Apr; 169(4):1287-90. PubMed ID: 12629344 [TBL] [Abstract][Full Text] [Related]
28. Localized non-conventional renal cell carcinoma: prediction of clinical outcome according to histology. Kim SH; Yang HK; Moon KC; Lee ES Int J Urol; 2014 Apr; 21(4):359-64. PubMed ID: 24224568 [TBL] [Abstract][Full Text] [Related]
29. Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients. Shek D; Tomlinson B; Brown M; Brunson A; Pan CX; Lara PN Clin Genitourin Cancer; 2012 Jun; 10(2):93-8. PubMed ID: 22382008 [TBL] [Abstract][Full Text] [Related]
30. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571 [TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base. Nese N; Paner GP; Mallin K; Ritchey J; Stewart A; Amin MB Ann Diagn Pathol; 2009 Feb; 13(1):1-8. PubMed ID: 19118775 [TBL] [Abstract][Full Text] [Related]
32. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. May M; Ficarra V; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Burger M; Gunia S; Feciche B; Wenzl V; Aziz A; Chun F; Becker A; Pahernik S; Simeone C; Longo N; Zucchi A; Antonelli A; Mirone V; Stief C; Novara G; Brookman-May S; ; J Urol; 2013 Aug; 190(2):458-63. PubMed ID: 23434943 [TBL] [Abstract][Full Text] [Related]